Ref. No. IVL 007/05/2018 May 10, 2018 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of Indorama

Ref. No. IVL 004/02/2020 26 February 2020 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of

Ref. No. IVL 005/11/2019 11 November 2019 The President The Stock Exchange of Thailand Subject: Submission of Quarterly Review of Financial Statements and the Management Discussion and Analysis of

referred to as “Corporate Group”) would like to clarify on the operating results according to the consolidated financial statements for the 3-month period and 6-month period ending June 30, 2017 as follows

person with regard to the purpose of investment, financial position and desire of such person; “related company” means (1) a company holding shares of twenty percent or more of all voting right shares of

statements for the 2nd quarter and 6-month period ending June 30, 2020 as follows. Description Year 2020 Year 2019 Increase / (Decrease) Million Baht Million Baht Million Baht % 2nd Quarter (April – June) Net

trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) Consolidated Financial Statements 2017 2016 +/(-) % Revenues from sales and services . . . . % Gross profit from

contracts and gain from the disposal of ordinary shares in joint venture companies • EBITDA stood at THB 33mn (down 74.9% YoY) largely as a result of the increase in unrealised loss on exchange rate. EBITDA

Attn: President Stock Exchange of Thailand Demeter Corporation Public Company Limited (“DCORP” or the “Company”) would like to submit the reviewed financial statements for first quarter of the year 2020

171 million Baht. The main reason is the effect from the gain of control in subsidiaries in the consolidated statements of comprehensive income for the year ended 31 December 2017 amounting to 7,113